Spasticity treatment market size is estimated to grow by USD 1.11 billion from 2022 to 2026 at a CAGR of 4% with the drug therapy having largest market share. Growing incidence of chronic diseases and health conditions will be a key driver fueling the spasticity treatment growth during the forecast period.